Sponsored by:

Complimentary ON DEMAND Ebinar

Recorded on September 6, 2022
12:00 Noon - 4:00 PM ET

Complimentary Webinar

Cannabis Extraction Virtual Conference

The Cannabis Extraction Virtual Conference is back! We are hosting this complimentary collection of webinar presentations, designed to help attendees better understand some of the more technical aspects of the cannabis extraction market. We will take a deep dive into cannabis and hemp extraction, the business behind extraction, post-processing, solvent remediation, optimization, GMPs and more. Take a look at the presentations and speakers below for more information.

Attendees registering for this complimentary series of webinars will get access to veterans in the cannabis extraction space, who are all available for Q&A after each presentation. In addition to getting the opportunity to chat with these subject matter experts on September 6, a recording of the presentations will be made available to all who register.

Practical and educational information from experts in the cannabis extraction market, all on the same day and all from the comfort of your home or office. Want real inside knowledge on cannabis extraction? Sign up today!

Who Should Attend:

  • Cannabis extraction personnel
  • Extraction Lab managers, Chemists, Extractors
  • Investors in extraction operations
  • Dispensary managers
  • Distributors, growers, and those looking to learn more about cannabis extraction


12:00 PM - Welcome & Introductions
Aaron Biros, Editor, CannabisIndustryJournal.com - Host and Moderator

12:05 PM - “Solvent Remediation – The Last Step for Safe, Clean Hemp Extraction”
Tom Bisbee, Production Director, EcoGen Biosciences

Attendees can expect to learn:

    • Understanding solvent remediation technology and processes
    • Residual solvents present huge risks
    • Consumers deserve transparency

12:55 PM - TBA - Sponsored TechTalk

1:10 PM -Advancing Cannabinoid Therapeutics Through Regulated Drug Discovery
Matthew Anderson, CEO, Vanguard Scientific
Nick Herbst, VP of Engineering, Vanguard Scientific
Brian Brandley, Ph.D., Laboratory Director, Biopharmaceutical Research Co.

  • A panel discussion with Dr. Brian Brandley, the CSO of Biopharmaceutical Research Company, a DEA-licensed pharmaceutical company that is pioneering the legal cannabis space in the U.S. through the development of federally compliant active pharmaceutical ingredients (API) for plant-based therapeutics, and Nick Herbst, VP of Engineering at Vanguard Scientific, and the Lead Engineer for the Company's MIDAS SCCO2 Extraction Program. During this 45-minute round table discussion moderated by Vanguard's CEO Matthew Anderson, the panelists will provide an overview of what it takes to make 'pharmaceutical-grade' cannabis products. The conversation will range from facility requirements, methods development, equipment qualification, process validations and more. 

2:00 PM -  TBA - Sponsored TechTalk

2:15 PM - "GMPs for Cannabis Extraction: Don't Overcomplicate it" 
Andrew Cole, Director, Client Delivery Audits, Cannon Quality Group

Attendees can expect to learn about:

  • Understanding the basics in plain English.
  • Learn what you need to do to meet minimum Industry expectations for Quality and Scalability. 
  • Implementation Strategies - Keep it simple. 

3:05 PM -  TBA TechTalk

3:20 PM - TBA Session

4:10 PM - Event Wrap Up


Tom Bisbee

Tom Bisbee
Production Director
 EcoGen Biosciences

Tom Bisbee, Production Director at EcoGen Biosciences, is an experienced hemp industry professional with a mind for solution-oriented problem solving. By utilizing the skills and techniques developed while earning degrees in Biophysics and Applied Mathematics from University of Colorado Boulder, he is able to analyze a situation from multiple differential perspectives and determine an efficient and optimal approach to proposing a solution. Tom’s expertise lies in the newly formed hemp industry in facility planning and development, operations and project management, business development, and team management.

Matthew Anderson

Matthew Anderson
Vanguard Scientific Systems, Inc.

Matthew Anderson is the CEO of Vanguard Scientific Systems, Inc. As CEO Of Vanguard Scientific, he has directed the development of novel SCCO2 extraction technology, captured and expanded sales across 8 countries and has taken part in speaking engagements around the world, including Tel Aviv, Cape Town, Toronto, multiple USA venues. Prior to joining Vanguard Scientific, Anderson was a partner in MacArthur Capital, LLP, focusing on due diligence, business development and SME asset cultivation.

Nick Herbst

Nick Herbst
Acting Vice President, Engineering
Vanguard Scientific Systems, Inc.

Nicholas Herbst is the acting Vice President of Engineering for Vanguard Scientific Systems. After completing a double major in Mechanical Engineering and Physics from Portland State University, Nick started working for Vanguard Scientific in 2018 and quickly developed a zeal for cutting edge botanical extraction solutions with a focus on supercritical CO2 extraction. During his time with Vanguard Scientific, Nick has spearheaded development of the MIDAS system for use in pharmaceutical grade CO2 extraction operations. In his spare time, Nick works on advancing the field of CO2 extraction for various applications, from hemp concentrate production to high purity essential oil isolation.

Dr. Brian Brandley

Dr. Brian Brandley
Laboratory Director
Biopharmaceutical Research Co.

Dr. Brandley graduated from the University of Miami with a BS and MSc in biology, and completed his PhD with a Fulbright-Hayes Fellowship at the University of Sydney.  Following a postdoctoral fellowship in the Department of Pharmacology and Molecular Sciences at The Johns Hopkins School of Medicine, Dr. Brandley helped initiate the first of several start-up biotech companies.  He spent the majority of his professional career working in drug discovery and development, with emphasis on oncology, immunology and inflammatory disease indications.  In his current role, Dr. Brandley is Laboratory Director at Biopharmaceutical Research Company (BRC), a company dedicated to producing federally compliant, GMP cannabis and cannabis-derived materials for use by academic and clinical researchers

Andrew Cole

Andrew Cole
Cannon Quality Group

Andrew Cole is Director at the Cannon Quality Group, specializing in Cannabis, Pharmaceuticals, Cosmetics, & Med Tech. With over 23 years of Quality/Regulatory and pragmatic compliance, he has extensive experience in GMP's & Regulatory Requirements. His expertise is in the application of ISO related standards, Medical Device Regulations, FDA CFR’s, EU GMP, Cosmetics and Pharmaceuticals, Medicinal and Recreational Cannabis regulation, and 10 years of developing supply chain compliance solutions. While working for multiple international companies, he has successfully completed major projects to Implement, Remediate, Eliminate Deficiencies, Gaps in management systems, and Risk Based Thinking. 

Aaron Biros

Aaron Biros
Cannabis Industry Journal.com

Aaron Biros is the Editor-in-Chief of Cannabis Industry Journal.com (CIJ), an online business-to-business trade journal focused on the legal cannabis industry. Biros started CIJ in 2015 when he officially joined Innovative Publishing full time. Through editorial coverage of the cannabis markets, Biros has developed a familiarity with regulatory compliance, quality and safety issues as they relate to the burgeoning cannabis industry. Biros covers science and technology updates, breaking news, regulations and emerging markets from his office based in Jackson Hole, Wyoming.